Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.CSCI
Alternate Symbol(s):
CSCI
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CSCI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Sep 12, 2024 6:35pm
RE:Those suffering osteoarthritis, diabetes, and heart disease
Avenanthramide could affect so many conditions many of which tend to be common to the same patients. ---- Avenanthramides, unique phenolic compounds found in oats, have been shown to have a
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Sep 12, 2024 6:08pm
Those suffering osteoarthritis, diabetes, and heart disease
Osteoarthritis (OA) is a prevalent chronic condition that significantly impacts various aspects of health, particularly in relation to cardiovascular diseases (CVD) and diabetes. The interplay between
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Sep 12, 2024 5:52pm
Fibrosis and heart disease
Perplexity Ai's take: The article titled "Modulating pro-fibrotic macrophages using yeast beta-glucan microparticles prepared by Pressurized Gas eXpanded liquid (PGX) Technology®"
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Sep 12, 2024 2:29pm
Osteoarthritis
PGX-produced yeast beta-glucan impregnated with avenanthramide presents a compelling treatment option for osteoarthritis (OA), particularly in light of recent preclinical studies demonstrating the
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Sep 12, 2024 1:54pm
RE:RE:Final Copy Published
Could have implications for a wound healing franchise. Ai can hallucinate but here's one take: Enhanced Macrophage Uptake The integration of avenanthramides into YBG could leverage the
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Sep 12, 2024 1:25pm
RE:Final Copy Published
In addition to the potential to treat fibrotic diseases there's a lot in that article with potential significant implications for PGX-YBG as an immune booster, and as a potential bioactive carrier
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Sep 12, 2024 5:16am
Final Copy Published
Modulating pro-fibrotic macrophages using yeast beta-glucan microparticles prepared by Pressurized Gas eXpanded liquid (PGX) Technology® - ScienceDirect
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Sep 12, 2024 5:01am
Dual action
Dual action: Avn-C not only shows anti-inflammatory properties but also demonstrates a protective effect on cartilage, potentially offering a two-pronged approach to osteoarthritis treatment.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Sep 11, 2024 8:42am
NSAIDs, osteoarthritis, and avenanthramide
Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Size The global NSAIDs market is substantial and growing: Valued at USD 20.70 billion in 2022 Projected to reach USD 32.64 billion by
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Sep 09, 2024 7:37am
CVS.com for wellness objectives
Simply better brands has been having a successful rollout of its Trubar which helps people meet their wellness objectives. CSCI is developing a neutraceutical wellness brand and also has a brand for
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Sep 08, 2024 1:06pm
RE:Perplexity Ai's suggested pricing, margin, and marketing
At that monthly pricing if a product was used every month you can see how it could add up over a one year period. Could Dr. Li, for instance, etc. help drive 100,000 customers to annual consumption
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Sep 08, 2024 11:20am
Perplexity Ai's suggested pricing, margin, and marketing
Based on the information provided, here is a suggested pricing, margin, and marketing strategy for Cosciens Biopharma's programs: Pricing Strategy Oat Beta Glucan Chewable
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Sep 07, 2024 10:28pm
RE:There's a recent SCHEDULE 13D filing of interest
The fund owning shares... Peter Puccetti is a prominent figure in the Canadian investment management industry, primarily known for his role at Goodwood Inc. Here's what we know
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Sep 07, 2024 10:22pm
There's a recent SCHEDULE 13D filing of interest
EOM
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >